Caris Life Sciences® is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings, Caris Molecular Intelligence® and ADAPT Biotargeting System™, assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. To learn more, please visit www.CarisLifeSciences.com or follow us on Twitter (@CarisLS).